Compounds > 5-(2,3,5-trichlorophenyl)pyrimidine-2,4-diamine ethane sulfonate
Page last updated: 2024-09-03

5-(2,3,5-trichlorophenyl)pyrimidine-2,4-diamine ethane sulfonate and Anterior Choroidal Artery Infarction

5-(2,3,5-trichlorophenyl)pyrimidine-2,4-diamine ethane sulfonate has been researched along with Anterior Choroidal Artery Infarction in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Andiné, P; Bona, E; Gilland, E; Hagberg, H; Puka-Sundvall, M1
Meldrum, BS; Smith, SE1

Other Studies

2 other study(ies) available for 5-(2,3,5-trichlorophenyl)pyrimidine-2,4-diamine ethane sulfonate and Anterior Choroidal Artery Infarction

ArticleYear
Hypoxic-ischemic injury in the neonatal rat brain: effects of pre- and post-treatment with the glutamate release inhibitor BW1003C87.
    Brain research. Developmental brain research, 1994, Nov-18, Volume: 83, Issue:1

    Topics: Animals; Animals, Newborn; Brain; Brain Damage, Chronic; Cerebral Infarction; Excitatory Amino Acid Antagonists; Female; Functional Laterality; Hypoxia, Brain; Ischemic Attack, Transient; Male; Organ Size; Premedication; Pyrimidines; Rats; Rats, Inbred WF

1994
Cerebroprotective effect of lamotrigine after focal ischemia in rats.
    Stroke, 1995, Volume: 26, Issue:1

    Topics: Animals; Brain Ischemia; Cerebral Infarction; Drug Administration Schedule; Drug Evaluation, Preclinical; Excitatory Amino Acid Antagonists; Lamotrigine; Male; Piperazines; Pyrimidines; Rats; Rats, Inbred F344; Sodium Channels; Triazines

1995